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Background: Heterozygous mutations in the chromatin remodeling gene CHD7 cause CHARGE syndrome, a developmental dis-
order with variable craniofacial dysmorphisms and respiratory difﬁculties. The molecular etiologies of these malformations are
not well understood. Homozygous Chd7 null mice die by E11, whereas Chd7Gt/1 heterozygous null mice are a viable and excel-
lent model of CHARGE. We explored skeletal phenotypes in Chd7Gt/1 and Chd7 conditional knockout mice, using Foxg1-Cre to
delete Chd7 (Foxg1-CKO) in the developing eye, ear, nose, pharyngeal pouch, forebrain, and gut and Wnt1-Cre (Wnt1-CKO) to
delete Chd7 in migrating neural crest cells. Results: Foxg1-CKO mice exhibited postnatal respiratory distress and death, dysplasia
of the eye, concha, and frontal bone, hypoplastic maxillary shelves and nasal epithelia, and reduced tracheal rings. Wnt1-CKO
mice exhibited frontal and occipital bone dysplasia, hypoplasia of the maxillary shelves and mandible, and cleft palate. In con-
trast, heterozygous Chd7Gt/1 mice had apparently normal skeletal development. Conclusions: Conditional deletion of Chd7 in
ectodermal and endodermal derivatives (Foxg1-Cre) or migrating neural crest cells (Wnt1-Cre) results in varied and more severe
craniofacial defects than in Chd7Gt/1 mice. These studies indicate that CHD7 has an important, dosage-dependent role in devel-
opment of several different craniofacial tissues. Developmental Dynamics 243:1055–1066, 2014.VC 2014 The Authors Developmen-
tal Dynamics published by Wiley Periodicals, Inc. on behalf of American Association of Anatomists.
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Introduction
Heterozygous mutations in the gene encoding CHD7, a chromatin
remodeling protein, are found in the majority of individuals diag-
nosed with CHARGE syndrome, a multiple anomaly disorder
defined by ocular coloboma, heart defects, atresia of the choanae,
retarded growth and development, genital and/or urinary abnor-
malities, and ear abnormalities (Janssen et al., 2012; Husu et al.,
2013). Craniofacial dysmorphisms are common in CHARGE syn-
drome, and include square-shaped facies, facial asymmetry,
external ear anomalies, cleft lip and/or palate, cranial nerve pal-
sies, and torticollis (Zentner et al., 2010; Hughes et al., 2014). In
addition, less penetrant phenotypes are associated with CHARGE
and include vertebral and limb anomalies, renal anomalies, and
tracheal hypoplasia or tracheo-esophageal fistula (Zentner et al.,
2010; Janssen et al., 2012; Legendre et al., 2012).
Understanding the role of CHD7 during organogenesis is criti-
cal for the development of effective therapies. We have generated
mouse models of CHARGE syndrome to examine molecular
mechanisms of Chd7 deficiency, including Chd7 loss of function
(Chd7Gt) and Chd7 conditional deletion (Chd7flox) alleles (Hurd
et al., 2007, 2010). Previous studies indicate that heterozygous
Chd7 mutant mice exhibit many phenotypes similar to human
CHARGE, including vestibular disorders, deafness, reduced
growth, pubertal delay, olfactory dysfunction, and brain abnor-
malities (Bosman et al., 2005; Adams et al., 2007; Hurd et al.,
2007, 2010, 2011, 2012; Layman et al., 2009, 2011; Yu et al.,
2013). Despite the myriad of skeletal abnormalities reported in
humans with CHARGE (Prasad et al., 1997; Wright et al., 2009),
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mice. Because homozygous Chd7Gt/Gt mice do not survive beyond
E11 (Bosman et al., 2005; Hurd et al., 2007), we chose to focus on
Chd7Gt/1 and Chd7 conditional knockout mice using Foxg1-Cre
(Hebert and McConnell, 2000) and Wnt1-Cre (Danielian et al.,
1998) mice. The complementary expression profiles of these two
different mouse lines in neural crest (Wnt1-Cre) and various ecto-
dermal/endodermal derivatives (Foxg1-Cre) provided an opportu-
nity to delineate the effects of loss of Chd7 in development of
various craniofacial structures.
Results
Chd7 Deﬁcient Mice Have Craniofacial Defects
The developmental origins of CHARGE-related birth defects are
not fully understood. Neural crest-derived tissues are commonly
affected by CHD7 deficiency (Bajpai et al., 2010), yet ectodermal
structures including the brain are also affected (Legendre et al.,
2012; Yu et al., 2013). To explore the relative contributions of
CHD7 in these tissue derivatives to organ development, we gener-
ated mice with loss of Chd7 using Foxg1-Cre, which is expressed
by E7.5 in the pharyngeal arches, facial and head ectoderm, otic,
optic, nasal and oral epithelium, pharyngeal arches, forebrain,
and foregut (Hebert and McConnell, 2000). We also generated
mice with Chd7 deletion using Wnt1-Cre, which is expressed by
E8.5 in developing pharyngeal arches, head mesenchyme, inner
ear, neural crest, midbrain, spinal cord and nasal neural crest and
mesenchyme (Danielian et al., 1998). Mice with deletion of both
Chd7 alleles by Foxg1-Cre or Wnt1-Cre are hereafter referred to
as Foxg1-CKO or Wnt1-CKO, respectively.
While Chd7Gt/1 mice survive to adulthood (Bosman et al., 2005;
Hurd et al., 2007), both Foxg1-CKO and Wnt1-CKO mice die shortly
after birth, likely from respiratory failure (neither Foxg1-CKO nor
Wnt1-CKO pups had milk in their stomachs). We, therefore, focused
our phenotypic analysis of craniofacial and other tissues on post-
natal day 1 pups. Chd7 wild type, Chd7flox/1, and Chd7Gt/1 mice
had no apparent abnormalities of the skull or craniofacial regions
(Fig. 1A,B). In contrast, Foxg1-CKO mice had severely hypoplastic
eyes (N¼ 7/7 mice) and shortened faces (Fig. 1C) and Wnt1-CKO
mice had shortened snouts (Fig. 1D). We performed comprehensive
measurements of craniofacial distances on skeletal preparations of
postnatal day 1 mice (Figs. 1E–H, 2; Table 1). We observed no differ-
ences in the degree of ossification in the skulls or in craniofacial
measurements (occipital bone, intersquamosal, interocular, mandi-
ble, or rostral-caudal lengths) between Chd7Gt/1 mice and wild type
or Chd7flox/1 littermate controls (Table 1), suggesting that loss of
one Chd7 allele does not cause major or highly penetrant skeletal
defects in mice. We did note mild hypoplasia of the ethmoid bone of
Chd7Gt/1 mice relative to controls (Fig. 1F).
In contrast, we observed significant frontal bone dysplasia
(either reduced ossification or hypoplasia) in both Foxg1-CKO
(N¼ 7; P< 0.05) and Wnt1-CKO (N¼ 7; P< 0.05) mice compared
with littermate controls (Figs. 1E–H, 2A–D). Of interest, there was
no dysplasia of the atlas (C1), axis (C2) or parietal/interparietal
bones, or change in rostral-caudal lengths of Chd7Gt/1, Foxg1-
CKO, or Wnt1-CKO mice compared with controls. Some mice had
dysplastic ribs, but this was infrequent, also occurred in controls,
and did not correlate with changes in rib number or vary signifi-
cantly across genotypes. Clavicles were also normal in mice of all
genotypes. Notably, the ethmoid bones were hypoplastic in both
Foxg1-CKO andWnt1-CKO mice, and the occipital region appeared
dysplastic in Wnt1-CKO mice (Fig. 1G,H). Foxg1-CKO mice exhib-





















Fig. 1. Conditional deletion of Chd7 results in ocular hypoplasia and
cranial bone dysplasia. Brightfield images (A–D) and skeletal prepara-
tions (E–H) of postnatal day 1 control (Cre-negative, Chd71/f or Chd7f/f)
(A,E), Chd7Gt/1 (B,F), Foxg1-CKO (C,G), and Wnt1-CKO (D,H) pups.
Chd7Gt/1 mice appear similar to controls, whereas both Foxg1-CKO (C)
and Wnt1-CKO (D) mice have shortened snouts, and Foxg1-CKO mice
have ocular hypoplasia (arrows in C and G). There are no abnormalities
in ossification, overall morphology or size of major craniofacial bones in
Chd7Gt/1 mice (B,F). In E–H, alizarin red and alcian blue staining reveal
bone and cartilage, respectively. Ethmoid bones are hypoplastic in
Chd7Gt/1 (F), Foxg1-CKO (G), and Wnt1-CKO (H) mice (white dashed
lines in E–H). Wnt1-CKO mice (H) have a more rounded posterior cra-
nium (indicated by arrows) than mice of other genotypes. Cre expres-
sion in Foxg1-Cre and Wnt1-Cre mice was detected using ZsGreen
reporter mice and compared with CHD7 protein levels in the develop-
ing eye (I–L). Shown are transverse sections of Cre;ZsGreen positive
E11.5 embryos stained with DAPI (labels cellular nuclei) or anti-CHD7
(red). Foxg1-Cre is active in CHD7-positive cells in the retina (r) and
posterior lens (l) of the developing eye (J), whereas Wnt1-Cre is
restricted to the surrounding periocular mesenchyme and is absent in
the retina and lens proper (L). Scale bars¼ 1 mm in E–H.
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4.66 mm; N¼ 7; P< 0.05) and intersquamosal distances (mean¼
5.90 vs. 6.58 mm, N¼ 7; P< 0.05) compared with controls (Fig. 2C
vs. A and Table 1), whereas Wnt1-CKO mice exhibited normal
interocular or intersquamosal distances, occipital bone dysplasia
and reduced mandibular length (mean¼ 4.95 vs. 5.55 mm; N¼ 7;
P< 0.05) (Fig. 2D vs. A and Table 1). Intersquamosal and interocu-
lar distances were similar in Chd7Gt/1 mice (Fig. 2B) and controls
(Fig. 2A). Thus, whereas Chd7Gt/1 mice appear normal, both
Foxg1-CKO and Wnt1-CKO mice displayed severe but distinct cra-
niofacial anomalies, suggesting that proper Chd7 expression within
the facial ectoderm (Foxg1) and neural crest (Wnt1) is required to
ensure normal craniofacial development.
Cre Transgene and Chd7 Expression in Developing
Retina Correlate With Ocular Defects
Chd7 is expressed in mouse embryonic stem cells (Schnetz et al.,
2009) and broadly in early (E7.5–E8.5) developing mouse embryos
(Randall et al., 2009), then by mid-gestation (E12.5) becomes
restricted to specific organs and tissues such as the brain, pituitary,
ear, heart, and craniofacial structures (Hurd et al., 2007). To charac-
terize Chd7 expression relative to Foxg1-Cre and Wnt1-Cre trans-
gene expression, we performed immunofluorescence for CHD7 on
E11.5 transgenic embryos that also contained ZsGreen reporter
(Madisen et al., 2010) alleles (Fig. 1I–L). CHD7 was present in the ret-
inae of both Foxg1-Cre;ZsGreen1 and Wnt1-Cre;ZsGreen1 E11.5
embryos. Consistent with published results, Foxg1-Cre, but not
Wnt1-Cre expression was observed in the E11.5 mouse retina (Fig.
1J vs. L) (Danielian et al., 1998; Hebert and McConnell, 2000). Thus,
deletion of Chd7 in Foxg1-CKO retina (with resultant hypoplastic
eyes) and preservation of Chd7 (with normal eyes) in Wnt1-CKO
mice is expected given these expression patterns.
Foxg1-CKO Mice Have Upper and Lower Airway
Abnormalities Including Conchae Dysplasia and
Hypoplastic Nasal Epithelia
Individuals with CHARGE syndrome have highly penetrant





















Fig. 2. Chd7 conditional mutants have shortened intraocular and intersquamosal distances, hypoplasia of the maxillary shelves, and dysplasia of
nasal conchae. Skeletal preparations of postnatal day 1 control (Cre-negative, Chd71/f or Chd7f/f) (A,E), Chd7Gt/1 (B,F), Foxg1-CKO (C,G), and Wnt1-
CKO (D,H) mice. Alizarin red and alcian blue staining show bone and cartilage, respectively. A–D: are representative dorsal images of the calvaria while
(E–H) are representative dorsal images of the developing maxillary shelves (with mandibles removed). Foxg1-CKO (C) mice exhibit shorter interocular
(white line, IO; P< 0.001; N¼ 7) and intersquamosal (white line, IS; P< 0.001; N¼ 7) distances compared with control (A), Chd7Gt/1 (B), and Wnt1-
CKO (D) mice. Foxg1-CKO (C) mice exhibit a visibly smaller frontal bone (FB) surface area (white, dotted line) relative to control (A), Chd7Gt/1 (B), and
Wnt1-CKO (D) mice. Wnt1-CKO (D) mice lack frontal bone ossification (as demonstrated by alizarin red staining) relative to control (A), Chd7Gt/1 (B),
and Foxg1-CKO (C) mice. In control (E) and Chd7Gt/1 (F) mice, appropriately formed palatal shelves (asterisk) and ventral nasal conchae (white arrow)
are present. Foxg1-CKO (G) mice have hypoplastic palatal shelves which approximate the midline (asterisk) and absent ventral conchae (white arrow),
whereas Wnt1-CKO (H) mice have severe palatal shelf hypoplasia (asterisk) and dysplastic ventral conchae (white arrow). Scale bars¼ 1 mm in A–D.
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tracheoesophageal fistula, and hyposmia or anosmia (Zentner
et al., 2010; Bergman et al., 2011; Layman et al., 2011). Chd7
mutant mice are known to have severely reduced olfactory abil-
ities and olfactory bulb hypoplasia, as well as choanal defects
(Bosman et al., 2005; Layman et al., 2009; Bergman et al., 2010),
but to date there is no detailed information about upper and
lower airway structures. We asked whether Chd7 heterozygous
and conditional mutant mice also exhibit airway dysplasia by
analyzing the structure of the oral/nasal cavity in skeletal prepa-
rations of postnatal day 1 pups. The majority of Chd7Gt/1 mice
(N¼ 4/6) and all Foxg1-CKO (N¼ 7/7) and Wnt1-CKO (N¼ 7/7)
mice displayed ventral conchae dysplasia (Fig. 2; Table 1). Simi-
larly, the majority of Chd7Gt/1 mice (N¼ 5/6) and all Foxg1-CKO
(N¼ 7/7) and Wnt1-CKO (N¼ 7/7) pups displayed dorsal conchae
dysplasia (Fig. 2; Table 1). Analysis of histologically stained sec-
tions revealed normal nasal epithelial tissues in Chd7Gt/1 and
Wnt1-CKO mice, despite hypoplasia of the dorsal and ventral
conchae in the latter (Fig. 3B,C). In contrast, the nasal epithelium
in Foxg1-CKO mice was severely disorganized and hypoplastic
(Fig. 3D). Comparison of X-gal staining in Chd7Gt/1 and Foxg1-
CKO mice (both of which contain the Chd7Gt allele that expresses
b-galactosidase under the control of the Chd7 promoter, [Hurd
et al., 2007]) showed that Chd7 promoter activity is preserved in
the nasal epithelium of both mutants, and that unlike Chd7Gt/1
mice which exhibit normal nasal epithelia, the Foxg1-CKO nasal
epithelium is severely disrupted (Fig. 3E vs. F). Together, these
data suggest that dysplasia of the nasal epithelium in mice with
reduced Chd7 may result primarily from disruption of normal
Chd7 expression in the ectoderm rather than a secondary defect
in neural crest cell migration.
Foxg1-CKO and Wnt1-CKO Mice Have Palatal Defects
Clefting of the lip and/or palate is reported in 33–48% of individ-
uals with CHARGE syndrome (Zentner et al., 2010; Bergman
et al., 2011). In addition, approximately one-third of Chd7whi/1
heterozygous mutant mice have cleft palates (Bosman et al.,
2005). By gross morphological analysis, we found no hard or soft
palatal defects in postnatal day 1 Chd7Gt/1pups (Figs. 2F, 3B).
Foxg1-CKO mice exhibit mild palatal shelf hypoplasia (N¼ 7/7);
however, do not exhibit cleft palates (N¼ 0/7; Table 1; Figs. 2G
and 3D). By contrast, all Wnt1-CKO mice (N¼ 7) exhibited severe
palatal shelf hypoplasia and some (N¼ 3/7) Wnt1-CKO mice dis-
played complete clefting of the palate resulting in an open oral/
nasal pharynx (Figs. 2D, 3C; Table 1). X-gal stained sections from
Chd7Gt/1 and Foxg1-CKO mice, showed b-galactosidase activity
(Chd7 promoter activity) in epithelial cells lining the palatal
shelves (Fig. 3E,F). Together, these data provide evidence that
Chd7 is highly expressed in the nasal/oral epithelium and may
contribute to disrupted palatal formation.
Absence of Long Bone, Vertebral, Clavicular, and
Pelvic Defects in Chd7 Mutant Mice
It has been proposed that CHARGE may be considered a skeletal





















TABLE 1. Foxg1-Cre or Wnt1-Cre Conditional Loss of Chd7 in Mice Results in Multiple Skeletal Abnormalities












Cranium Interocular distance 4.66 4.34 3.72b 5.12 5.01
Frontal bone dysplasiaa 3 4 7b 0 6b
Eye dysplasiaa 0 0 7b 0 0
Intersquamosal distance 6.58 6.38 5.90b 6.23 6.24
Parietal/interparietal bone dysplasiaa 0 0 0 0 0
Occipital bone length 3.92 4.10 3.86 3.58 3.47
Occipital bone dysplasiaa 0 0 0 1 7b
Rostral-caudal length 9.54 9.27 8.99 9.75 9.46
Ventral conchae dysplasiaa 0 4b 7b 1 7b
Dorsal conchae dysplasiaa 0 5b 7b 1 7b
Palatal shelf dysplasiaa 0 0 7b 1 7b
Cleft palatea 0 0 0 0 3b
Mandible length 5.29 5.28 5.05 5.55 4.95b
Cervical spine Atlas (C1) dysplasiaa 0 0 0 0 0
Axis (C2) dysplasiaa 0 0 0 0 2
Thoracic spine Rib count 13.0 13.0 12.9 12.9 12.9
Rib dysplasia (bifid)a 1 3 1 2 4
Thorax Clavicle length 2.49 2.49 2.48 2.60 2.56
Tracheal ring count 17.8 19.3 11.0b 16.7 18.9
All measurements are in millimeters.
aThese observations were scored in a binomial fashion (e.g. dysplasia of the frontal bone was identified as “present” or “absent”).
As such, the number of mice affected is scored across each genotype for each observation.
bSignificance indicated at p<0.05 relative to Chd71/flox (for Foxg1-Cre) or control (Chd71/flox or Chd7flox/flox for Wnt1-Cre) by
MANOVA with post hoc Tukey’s HSD test.
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et al., 2007; Wright et al., 2009), vertebral defects, and basioocci-
pital abnormalities (Fujita et al., 2009). We identified no visible
skeletal defects in postnatal day 1 control, Foxg1-Cre conditional
heterozygous (Foxg1-Cre;Chd71/flox), or Wnt1-Cre conditional
heterozygous (Wnt1-Cre;Chd71/flox) mice. Likewise, lengths of
bones in the upper extremity (humerus, ulna, or radius), pelvis
(intercrest, interspinous, or crest-symphysis) and lower extremity
(femur, tibia, or fibula) were similar in control, Chd7 heterozy-
gous null (Chd7Gt/flox), Foxg1-CKO, and Wnt1-CKO mice (data
not shown). Bones from the right and left sides of the body of all
mice were also similar across all genotypes, suggesting that loss
of Chd7 does not affect axial symmetry. We observed no verte-
bral anomalies suggestive of spinal curvature (data not shown).
Analysis of the cervical spine, thoracic spine (rib count or dyspla-
sia) and clavicle revealed no apparent differences between





















Fig. 3. Conditional Chd7 deletion results in palatal and nasal epithelial dysplasia. Transverse sections of postnatal day 1 control (Cre-negative,
Chd71/f or Chd7f/f) (A), Chd7Gt/1 (B), Wnt1-CKO (C), and Foxg1-CKO (D) mice stained with hematoxylin and eosin. Control (A) and Chd7Gt/1 (B)
mice exhibit fully fused palatal shelves (ps) with separation of the nasopharynx (np) from the oropharynx (op), whereas Wnt1-CKO(C) mice have
severely hypoplastic palatal shelves (ps) resulting in a cleft palate and single pharyngeal cavity (np/op). Foxg1-CKO mice (D) have fused palatal
shelves (ps) resulting in a highly arched, intact palate, a thickened nasal septum (asterisk), and severely hypoplastic nasal epithelia (ne). E,F: Show
X-gal/eosin stained sections of postnatal day 1 Chd7Gt mice, which express b-galactosidase under the control of the Chd7 promoter. X-gal stain-
ing is present in the nasal epithelium (ne), tongue (t) and epithelial cells lining the palatal shelves and combined oral-nasal pharynx (op/np) of
Chd7Gt/flox (E) and Foxg1-CKO (F) mice. Panels (G–J) are transverse sections of Foxg1-Cre;ZsGreen (G,H) or Wnt1-Cre;ZsGreen (I,J) E11.5
embryos stained with DAPI (blue, marking cellular nuclei) or anti-CHD7 (red). Green fluorescence (ZsGreen reporter) marks Cre expressing cells
and is overlaid with anti-CHD7 (red) in (H) and (J). Foxg1-Cre and Chd7 are both highly expressed in the developing nasal epithelium (ne) while
Wnt1-Cre expression is restricted to the surrounding nasal mesenchyme (m) and is absent from the nasal epithelium proper.
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(Table 1). Thus, at the level of resolution possible by analysis of
skeletal postnatal day 1 preparations, we found no defects in the
long bones, vertebrae, clavicles, or pelvis of Chd7 mutant mice.
Normal Development of Neural Crest Derived Cardiac
Structures in Wnt1-Cre Conditional Mutant Mice
Cardiac defects including abnormal development and septation
of the conotruncus and the development of the great vessels, are
present in 75–77% of individuals with CHARGE syndrome (Zent-
ner et al., 2010; Bergman et al., 2011; Janssen et al., 2012). In
mice, some Chd7Whi/1 embryos (heterozygous for a Chd7 null
allele) have been reported to have interventricular septal defects,
body edema and cardiac insufficiency (Bosman et al., 2005). In
Wnt1-Cre mice, Cre-positive neural crest cells (NCCs) migrate to
the conotruncus or early cardiac outflow tract, where they partic-
ipate in septation of this tract into the pulmonary and aortic out-
flow tracts (Jiang et al., 2000). Additionally, NCCs migrate from
the posterior hindbrain into the third, fourth and sixth pharyn-
geal arches where they participate in the asymmetric remodeling
of the pharyngeal arch arteries (PAA) into the great vessels (Hut-
son and Kirby, 2007). We, therefore, asked whether Wnt1-CKO
mutant mice also exhibit heart defects similar to or more severe
than those previously reported. To demonstrate whether NCC-
mediated conotruncal development is impacted by Chd7 deletion,
we assessed cardiac outflow tract development in Wnt1-CKO
embryos. At E16.5, a time point at which cardiac outflow tract
septation is complete, we observed grossly normal aortic and pul-
monary septation as well as normal formation of the major
branches off the aorta (N¼ 4 Conditional Heterozygous [CHet]
[Fig. 4A], N¼ 5 Wnt1-CKO [Fig. 4B]). Histologic analysis with
H&E staining of E16.5 Wnt1-CHet (N¼ 7; Fig. 4C) and Wnt1-
CKO (N¼ 6; Fig. 4D) hearts confirmed normal aorto-pulmonary
and right–left outflow tract septation. To determine whether neu-
ral crest-mediated PAA formation was impacted by Chd7 dele-
tion, we assessed PAA formation at E10.5 by India ink injection
in Wnt1-Conditional heterozygous (Fig. 4E) and Wnt1-CKO (Fig.
4F) mice. Third, fourth, and sixth PAA formation in Wnt1-Cre
expressing neural crest cells was unaffected by Chd7 deletion
(N¼ 5 CHet; N¼ 6 Wnt1-CKO). Thus, we found no evidence for
cardiac abnormalities in mice with Wnt1-Cre mediated condi-
tional deletion of one or both copies of CHD7.
Foxg1-Cre Chd7 Conditional Mutants Have Fewer
Tracheal Rings
Other mediastinal abnormalities, including tracheoesophageal fis-
tula and tracheal agenesis have also been reported at relatively
high penetrance (19–29%) in CHARGE syndrome (Zentner et al.,
2010; Bergman et al., 2011). Tracheal cartilage was readily visible
in the skeletal preparations of postnatal day 1 pups, allowing us
to characterize the mice for tracheal abnormalities. Of interest,
there were, on average, 17–18 tracheal rings in control mice
(N¼ 16), 19 in Chd7Gt/1 mice (N¼ 6), and 19 in Wnt1-CKO mice
(N¼ 7) (Fig. 5; Table 1). In contrast, Foxg1-CKO mice had, on
average, only 11 tracheal rings (P< 0.001; N¼ 7) (Fig. 5; Table
1). The severe reduction in tracheal rings may represent a devel-
opmental delay or arrest of tracheal development, and could con-
tribute to their early postnatal respiratory distress and death.
We then asked whether Chd7 and Wnt1-Cre/Foxg1-Cre
transgenes are expressed in the embryonic trachea proper or in
surrounding mesenchymal tissues (Woo et al., 2011). As in Fig-
ures 1 and 3, we stained cross-sections through E11.5 Foxg1-
Cre;ZsGreen1 and Wnt1-Cre;ZsGreen1 embryos at the level of
the mediastinum for immunofluorescence with anti-CHD7 anti-
body (Fig. 5E–H). We observed abundant CHD7 staining in the
presumptive esophagus and trachea, with less bright label in the
surrounding mesenchyme of Foxg1-Cre;ZsGreen1 embryos. Of
interest, Foxg1-Cre transgene activity was widespread in both the
tracheal epithelium and surrounding mesenchymal tissues (Fig.
5E,F), whereas Wnt1-Cre transgene activity was restricted to the
peri-tracheal mesenchyme (Fig. 5G,H). These data suggest that
CHD7 is concentrated in the tracheal primordium, and is also
expressed in adjacent mesenchyme, and that loss of CHD7 in the
tracheal primordium leads to severely disrupted tracheal
development.
Discussion
In this study, we present data showing that Chd7 is required for
certain aspects of murine craniofacial and mediastinal develop-
ment; specifically, loss of Chd7 disrupts formation of the orbit
and multiple regions of the respiratory tract. By using mice
expressing Cre recombinase in ectoderm- and endoderm-derived
cells of the developing telencephalon and pharyngeal arches
(Foxg1-Cre) and in migratory neural crest cells (Wnt1-Cre), we
identified components of the upper and lower respiratory tracts
that likely contribute to acute respiratory failure and perinatal
death of Chd7-conditional mutant mice. Interestingly, Chd7 is
required for proper development of multiple components along
the upper and lower respiratory tracts, including the nose, hard
palate, and trachea. Complex malformations of each of these
organs have been noted in humans with CHARGE syndrome, and
postnatal respiratory distress is a common cause for early mor-
bidity and mortality.
Upper and Lower Airway Malformations
With Chd7 Deﬁciency
Nasal conchae, or turbinates, are critical for air filtration and
proper formation and maintenance of the olfactory epithelium.
Specifically, the conchae provide increased nasal epithelial sur-
face area while humidifying the air, which may help protect
olfactory nerve axons traveling through the cribriform plate to
synapse in the olfactory bulb (Kim et al., 2003; Kastl et al., 2009).
These structures develop, in part, from the ethmoid bone, a com-
plex structure which forms the caudal nasal cavity (Jacob and
Chole, 2006). We found that Chd7Gt/1 mice exhibit mild hypopla-
sia of the dorsal and ventral conchae as well as the ethmoid
bone, whereas conditional deletion of Chd7 in Foxg1-Cre-
expressing mice resulted in complete loss of the nasal choanae
and ethmoid bone. Interestingly, Wnt1-CKO mice also exhibited
nasal conchae and ethmoid dysplasia, with little disruption to the
nasal passageways. Given the importance of the conchae in
olfactory development, their disruption could worsen olfactory
neuron dysfunction in Chd7 mutant mice and contribute to pre-
viously reported hyposmia/anosmia phenotypes (Layman et al.,
2009). In addition to disruption of the nasal conchae, we
observed marked disruption of the nasal passageways in Foxg1-
CKO mice, reminiscent of the posterior nasal aperture blockage or
choanal atresia reported in some Chd7Whi/1 mice (Bosman et al.,
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composed of facial ectoderm and migrating cranial neural crest
cells, and Chd7 may be necessary for proper integration of these
cell types. Interestingly, external naris occlusion impairs nasal
turbinate development in the mouse (Coppola and Craven, 2014),
evidence that development of the conchae is dependent on proper
airflow. We postulate that some of the nasal abnormalities
observed in Chd7 mutant mice reflect underlying contributions
of Chd7 to development of cells derived from neural crest, ecto-
derm, and underlying mesenchyme.
In addition to choanal atresia, other airway abnormalities such
as sinus blockage, cleft palate, and laryngomalacia, are common
in CHARGE syndrome (Zentner et al., 2010; Janssen et al., 2012;
Hughes et al., 2014). We observed thickening and vaulting of the
palatal shelves in Foxg1-CKO mice and complete cleft of the pal-
ate in Wnt1-CKO mice. In humans, highly arched palates indicate
disruptions in maxillary shelf development, are often reported
following cleft palate repair, and are commonly associated with
dental crowding and speech difficulties (Eppley et al., 2005;
Chapman et al., 2008; Wang et al., 2009). The occurrence of
highly arched palates has been documented in individuals with
CHARGE who have intact palates or following surgical repair of a
cleft palate (Akisu et al., 1998). Both Foxg1-Cre and Wnt1-Cre
are expressed in cells critical for maxillary development; indeed,





















Fig. 4. Neural crest-derived cardiac structures develop normally in Wnt1-CHet and Wnt1-CKO mice. E16.5 embryonic hearts from Wnt1-CHet (A)
and Wnt1-CKO (B) embryos exhibited normal septation of the aorta (Ao) and pulmonary trunk (PT) with normal extension of the brachiocephalic
(BCA), left common carotid (LCC), and left subclavian (LSA) arteries from the aortic arch. H&E staining of sectioned E16.5 embryonic hearts from
Wnt1-Cre conditional heterozygous (C) and Wnt1-CKO (D) mice revealed normal development of the left ventricular outflow tract (LVOT) and inter
ventricular septum (IVS). India ink injections of E10.5 Wnt1-Cre conditional heterozygous (CHet) (E) and Wnt1-CKO (F) mice demonstrate normal
development of the 3rd, 4th, and 6th pharyngeal arch arteries. Other abbreviations: RA (right atrium); LV (left ventricle); RA (right atrium); LA (left
atrium). Lines span lumina of arteries.
CHD7 IN CRANIOFACIAL AND TRACHEAL DEVELOPMENT 1061
these Cre recombinases results in mild and more severe maxillary
malformations including complete aplasia (Li et al., 2011; Wang
et al., 2011). Interestingly, we did not observe palatal vaulting or
clefting in our Chd7Gt/1 mice. This could be a result of low sam-
ple size or effects of genetic background. Cleft palate occurs in
25% of Chd7Whi/1 mice (Bosman et al., 2005) and 33–48% of
humans with CHARGE syndrome (Zentner et al., 2010; Janssen
et al., 2012). Together, these results suggest that Chd7 plays criti-
cal roles in Wnt1-Cre derived cranial neural crest cells that con-
tribute to osteogenesis and to the overlying Foxg1-Cre derived
oral epithelium, both of which are critical for proper maxillary
development (Bush and Jiang, 2012).
In addition to malformations of the upper airway, we observed





















Fig. 5. Foxg1-CKO mice have reduced numbers of cartilaginous tracheal rings. Shown are skeletal preparations of postnatal day 1 control (Cre-
negative, Chd71/f, or Chd7f/f) (A), Chd7Gt/1 (B), Foxg1-CKO (C), and Wnt1-CKO (D) mice. Alizarin red and alcian blue staining reveal bone and car-
tilage, respectively. Normal numbers of tracheal rings (17–19) (arrows point to distal trachea) are present in control, Chd7Gt/1, and Wnt1-CKO
mice, whereas Foxg1-CKO mice have fewer (11) tracheal rings. Panels E–H are transverse sections of Foxg1-Cre;ZsGreen (E,F) or Wnt1-Cre;Zs-
Green (G,H) E11.5 embryos at the level of the laryngotracheal groove (indicated by the area within the dashed white lines) stained with DAPI (blue,
labeling cellular nuclei) or anti-CHD7 (red). Green fluorescence (ZsGreen reporter) marks Cre-expressing cells and is overlaid with anti-CHD7 (red)
in (F) and (H). Chd7 and Foxg1-Cre are highly co-expressed in the developing esophagus (es), trachea (t), and the surrounding mesenchyme (m),
whereas Wnt1-Cre activity is restricted to the surrounding mesenchymal tissues and does not overlap with Chd7 expression in the presumptive
esophagus or trachea.
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This is consistent with high levels of Cre expression in the tra-
cheal primordium of Foxg1-Cre mice. Tracheal cartilage is critical
for maintaining patency of the trachea upon expiration (Doshi
and Krawiec, 2007). Thus Chd7 may play an intrinsic role in tra-
cheal development, consistent with the tracheal abnormalities
(malacia, dysgenesis, and agenesis) observed in individuals with
CHARGE. The proximity of foregut derivatives to the trachea and
the high incidence of tracheoesophageal fistula in CHARGE sug-
gest that CHD7 may be important for gut development (Perl
et al., 2002). Furthermore, we observed significant, colocalized
Chd7 and Foxg1-Cre activity in the presumptive esophagus sug-
gesting that development of the larygotracheal groove is critically
dependent on proper expression of Chd7. More detailed analysis
mice will be necessary to determine the extent to which Chd7
contributes to foregut development.
Potential Dual Roles for Chd7 in the Eye
Development of the eye involves a dual process whereby neuro-
ectoderm forms a proto-retinal outpouching from the rostral tel-
encephalon (Sinn and Wittbrodt, 2013). Upon contact with
growing retinal tissue, the overlying surface ectoderm induces
optic cup formation. The lens is the principal structure derived
from the overlying surface ectoderm. Recent reports suggest that
spatiotemporal localization of lens and retinal tissue is driven by
neural crest cells, which themselves differentiate into the sclera
separating the developing lens from the retina (Grocott et al.,
2011). These neural crest cells help direct the generation of the
optic cup, which involves a complex folding process resulting in
formation of the choroid fissure. In the mature eye, the choroidal
fissure is almost completely closed, providing continuity to the
inferior iris and retina. Defects in choroidal fissure closure present
as colobomata.
Ocular colobomata of the retina and/or iris, are sometimes
associated with microphthalmia, occur in 75–81% of individuals
with CHARGE syndrome (Zentner et al., 2010; Bergman et al.,
2011). Previous studies of Chd7Whi/1 mice showed keratocon-
junctivitis sicca (dry eye) (Bosman et al., 2005), but there are no
reports in Chd7 mutant mice of ocular coloboma or other major
eye defects commonly seen in CHARGE syndrome. One of our
most striking findings was severe hypoplasia of the eye in Foxg1-
CKO mice. Our immunofluorescence results from E11.5 mice also
demonstrate high levels of both Foxg1-Cre and CHD7 in retinal
tissue. Notably, in addition to the high CHD7 in retina, we
detected abundant CHD7 in the developing lens. We observe no
obvious defects in eye development in Wnt1-CKO mice, suggest-
ing that Chd7 may have subtle or no significant functions in neu-
ral crest cells that contribute to ocular development. Recent data
from zebrafish (D. rerio) have implicated chd7 in the regulation
of retinal cell specification (Patten et al., 2012); our data provide
the first evidence that loss of Chd7 within the retina contributes
to ocular malformations in mammals. Future studies of Chd7
function in the developing eye should help determine the mecha-
nistic relationship between ocular hypoplasia and colobomata.
Lack of Evidence for Chd7 Function in Cardiac Neural
Crest Cells
Fourth pharyngeal arch artery (PAA) hypoplasia and malforma-
tions of the transverse aorta and right subclavian artery (fourth
PAA derivatives) have been reported in Chd7Whi/1 mice (Randall
et al., 2009). Importantly, attempted rescue of these malforma-
tions using Wnt1-Cre, expressed in neural crest cells, and a con-
ditional Chd7 wild-type allele was unsuccessful, suggesting
minimal contributions of Chd7 in Wnt1-Cre lineages to heart for-
mation (Randall et al., 2009). Given these observations, we fur-
ther explored the role of cardiac neural crest by examining
conditional deletion of Chd7 using Wnt1-Cre. Neither Wnt1-con-
ditional heterozygous nor Wnt1-CKO mice exhibited any defor-
mity in PAA development at E10.5 or in arterial branching at
E16.5, consistent with minimal or no Chd7 function in cardiac
neural crest cells. Alternatively, Wnt1-Cre activity may be mosaic
or inefficient in the cardiac neural crest. Additional studies are
necessary to distinguish among these possibilities.
Development of Craniofacial Structures Requires
Correct Spatiotemporal Chd7 Expression
Our results demonstrate that proper expression of Chd7 is neces-
sary for development of the craniofacial structures contributing
to the upper respiratory tract and the cartilaginous rings of the
trachea. Two complementary themes emerge from our data: (1)
Chd7 expression is required in the surface ectoderm, endoderm,
and migrating neural crest cells which all contribute to the devel-
opment of facial structures and the eye and (2) Chd7 likely has a
significant role in the development of cartilage and bone. Foxg1-
Cre is highly expressed by E7.5 in surface ectoderm and endo-
derm which populate the pharyngeal arch and pouch derivatives,
respectively (Hebert and McConnell, 2000). Components of the
first pharyngeal arch contribute to many of the facial bones
affected in Chd7 deficient mice and humans, including the eth-
moid, maxilla, and mandible (Sperber, 1989). Migrating neural
crest cell populations expressing Wnt1-Cre invade pharyngeal
arch structures and are critical for their proper specification. Loss
of Chd7 in the embryonic frog (X. laevis) has been reported to
result in failed neural crest cell migration from the dorsal neural
tube (Bajpai et al., 2010). We found that disruptions to Chd7 in
Wnt1-Cre expressing neural crest cells results in developmental
abnormalities in the nose and palate, but not the heart. Of inter-
est, we observed phenotypic differences in the nose and palate
between Foxg1-CKO and Wnt1-CKO mice that may reflect differ-
ences in sites or timing of Cre activity. In Foxg1-Cre mice, Cre is
induced around E7.5, which may affect certain populations of
premigratory neural crest cells (Nichols, 1986), whereas Wnt1-
Cre is activated slightly later, at E8.5, in migratory neural crest
(Danielian et al., 1998). Much remains to be clarified regarding
how CHD7 regulates proper gene expression in both the facial
ectoderm and neural crest cells that contribute to craniofacial
development.
Our results highlight the potential role that CHD7 has in regu-
lating development of bone. Interestingly, a previous report sug-
gests that CHD7 is required for inducing Wnt5a-dependent
osteoblastogenesis in mesenchymal stem cells (Takada et al.,
2007). Indeed, these authors determined that reduction in Chd7
mRNA levels by RNAi caused a cell fate switch leading to the
accumulation of adipocytes. While this research was performed
using mesoderm-derived cell populations, CHD7 may function
similarly in craniofacial osteoblasts derived from cranial neural
crest cells (Minoux and Rijli, 2010). Further investigation is nec-
essary to determine the specific function(s) of CHD7 in develop-
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Experimental Procedures
Mice
Foxg1-Cre;Chd7Gt/1 mice and Chd7flox/flox mice were generated
and genotyped as previously described (Hurd et al., 2007, 2010).
Specifically, these mice were maintained on a mixed C57BL/
6;129S1/SvImJ background and inbred to N¼ 6–8. Mice of the
following genotypes were analyzed: control (Chd71/flox), Chd7
heterozygous mutant (Chd7Gt/flox or Chd7Gt/1), Foxg1 conditional
heterozygous mutant (Foxg1-Cre;Chd71/flox) and Foxg1condi-
tional knockout mutant (Foxg1-Cre;Chd7Gt/flox or Foxg1-CKO).
Wnt1-Cre;Chd71/flox mice were crossed with Chd7flox/flox mice,
and the following genotypes were analyzed: control (Chd71/flox
or Chd7flox/flox), Wnt1-Cre conditional heterozygous mutant
(Wnt1-Cre;Chd71/flox) and Wnt1conditional knockout mutant
(Wnt1-Cre;Chd7flox/flox or Wnt1-CKO). ZsGreen Cre reporter mice
(Madisen et al., 2010) (JAX#007906) were crossed with Foxg1-
Cre or Wnt1-Cre mice to identify sites of Cre positive cells. The
University of Michigan University Committee on the Use and
Care of Animals (UCUCA) approved all procedures.
Skeletal Preparations
Postnatal day 1 mice were terminally anaesthetized, eviscerated,
and fixed in 95% ethanol overnight and incubated in acetone for
3 days. Preparations were placed in dye solution (0.06 mg/ml
Alizarin Red (Sigma, St. Louis, MO) and 0.18 mg/ml Alcian Blue
(Sigma) in 42 ml of 72% ethanol and 3 ml of glacial acetic acid)
and agitated gently on a rotary shaker for 4 days. Skeletons were
washed in ddH2O for 2 hr to rinse excess dye then placed in 1%
KOH clearing solution for 2 days. Samples were then immersed in
increasing concentrations of glycerol (1:4 glycerol/1% KOH; 1:1
glycerol/1% KOH; 8:2 glycerol/1% KOH) for 5 to 7 days per
immersion. Finally, skeletal preparations were stored in 100%
glycerol, photographed using a Leica DMRB microscope and
measured using ImageJ (National Institutes of Health, Bethesda,
MD). Images were processed using Adobe Photoshop CS6 (Adobe,
San Jose, CA).
Histology and X-gal Staining
Postnatal day 1 mice were collected, decapitated and heads fixed
in 4% paraformaldehyde overnight at 4C. After washing in
phosphate buffered saline (PBS), heads were incubated in 30%
sucrose, embedded in OCT medium (Tissue-Tek, Torrance, CA),
frozen, and sectioned at 12–15 mm. Sections were either stained
with hematoxylin and eosin (H&E) (Sigma) for histological analy-
sis, or X-gal for expression analysis as previously described
(Hurd et al., 2007). Sections were photographed by light micros-
copy on a Leica upright DMRB microscope and processed in Pho-
toshop CS2 (Adobe, San Jose, CA).
Immunoﬂuorescence and Cre Lineage Tracing
For Cre lineage tracing and anti-CHD7 immunofluorescence,
E11.5 Foxg1-Cre;ZsGreen;Chd71/1 and Wnt1-Cre;ZsGreen;
Chd71/1 embryos were harvested, dissected, and embedded in
OCT cryosectioning media (Tissue-Tek, Torrance, CA). Embryos
were cryosectioned at 14 mm, stained with 1:7,500 anti-CHD7
rabbit IgG monoclonal antibody (in TSA block, #6505 Cell Sig-
naling Technology [Danvers, MA] and counterstained with 1:200
biotinylated anti-rabbit IgG goat secondary antibody (in TSA
block, BA-1000, Vector Laboratories [Burlingame, CA]). Strepavi-
din–horseradish peroxidase (1:100 in TSA block) was added to
slides and Alexa 555 tyramide (1:100 in Amplification Buffer,
Molecular Probes [Grand Island, NY]) was applied to generate flu-
orescence. DAPI (5 mg/ml) was added and slides mounted for
imaging using a Leica DMRB microscope. Final image processing
was performed using Adobe Photoshop CS6 (Adobe, San Jose,
CA).
Cardiac Evaluation
For gross inspection, E16.5 embryos were harvested and dis-
sected. For the hematoxylin/eosin stained sections, embryos were
fixed in 4% paraformaldehyde for 12–18 hr at 4C, dehydrated
and embedded in Leica Histowax according to standard proce-
dures. After embedding, sections were cut at 5–7 mm. Images
were analyzed by brightfield microscopy. For India ink injections,
E10.5 embryos were dissected and placed in ice cold PBS. Using a
pulled glass pipette, India ink was injected into the ventricles
until the ink penetrated the small vessels. Embryos were post-
fixed in 10% buffered formalin for 12 hr, dehydrated and cleared
in benzylbenzoate: benzyl alcohol (2:1v/v).
Statistical Analysis
Measurements of anatomical regions were performed on control
(N¼ 16), Chd7 heterozygous mutant (N¼ 6), Foxg1 conditional
heterozygous mutant (N¼ 7), Wnt1 conditional heterozygous
mutant (N¼ 2), Foxg1 conditional knockout mutant (N¼ 7), and
Wnt1 conditional knockout mutant (N¼ 7) mice using
stereoscope-standardized pictures analyzed with ImageJ
(National Institutes of Health, Bethesda, MD). Discrete observa-
tions (i.e., presence or absence of dysplasia) were scored in a
binomial manner. Bone lengths were measured using ImageJ
(National Institutes of Health, Bethesda, MD). All measurements
were analyzed in SPSS (v.19.0) by MANOVA with a post hoc
Tukey’s honest significant difference (HSD) test; significance was
limited to P 0.05.
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